Result
€79,311 ▲ 520%
The result rose in 2025 from €12,789 to €79,311.
Philotax
Overview
Lifetime
2 annual accounts with figures on one time axispeak €100,875 (2025)
€100,875▲ 519%
peak €79,311 (2025)
€79,311▲ 520%
peak €94,600 (2025)
€94,600▲ 519%
€22,516▲ 35.9%
Board1 name since 2024
1 directorVANHOOREBEECK Cedric
Documentsfilings and deeds
22-07-20269 days before the deadline
2025micro format
Gross margin from €16,305 to €100,875Result from €12,789 to €79,311Equity from €15,289 to €94,600Debts from €16,574 to €22,516Cash from €2,434 to €55,929
Key points
from the 2025 annual accountsInvestments
€7,798 9.3 × depreciation
Green is investment, beige is depreciation.
Liquidity
4.89 was 2.20 in 2024
Short-term debts rose from €14,474 to €22,516.
Checked score
98
Excellent
Financially stronger than 86% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2025: 0.1%
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026highest value
08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 4.89, cash €55,929
Equity €94,600 (80.8% of total assets)
Figures for financial year 2025 (filed on 22-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 81% on liquidity, 80% on profitability and 99% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as Philotax has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Philotax itself is lower: < 0.1% within 12 months. It rests on far more data about Philotax than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for Philotax. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €9,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 4.89 (2.2 in 2024), above the usual 1.5. Short-term debt is 19.2% and cash 47.8% of total assets. 19.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
9 days early
2024
7 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 2 accounts on average 1 day before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1014546160
Incorporation
Founding capital of €2,500, 100 shares · Founder: VANHOOREBEECK Cedric · Appointment: VANHOOREBEECK Cedric (director) · published on 04-10-2024 · Gazette deed
First establishment
Wittemoerstraat 2, Beernem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Philotax Beernem | €117,116 | €100,875 | 80.8% | - |
| Medisch G. Sierens Bruges | €109,995 | €104,821 | 72.1% | - |
| SALMONCO Neupré | €119,799 | €102,969 | 79.4% | - |
| LERIX Grobbendonk | €118,998 | €104,960 | 76.5% | - |
| DOCTEUR MARION HUBERT Waremme | €120,234 | €95,440 | 86.1% | - |
| société médicale Fanny KAESMACHER Donceel | €116,510 | €94,980 | 65.3% | - |
| Docteur A. IANCU Seraing | €126,521 | €107,834 | 1.2% | - |
These companies have the same main activity as Philotax: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €110,000 and €127,000, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 02-10-2024Normal situation
- Activity
- Specialist medical practiceNACE 86220and 2 others
- Establishment unit
- 2.365.264.5298730 Beernem, since 02-10-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 16-01-2026
Annual accounts 2025
- €100,875▲ 519%
- ≈ €190,000estimated
- €79,311▲ 520%
- €94,600▲ 519%
- €117,116▲ 268%
- Filing
- Filed on 22-07-2026, 9 days before the end of the filing period
Insights on Philotax
Philotax has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €94,600 and a net result of €79,311.
Its solvency ranks better than 71% of 20,767 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 22-07-2026, 9 days before the deadline€100,875
▲ 519%
€99,907
▲ 513%
€79,311
▲ 520%
€87,636
▲ 404%
80.8%
▲ 32.8 percentage points
4.89
▲ 2.69
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €190,000. Estimated: probably between €160,000 and €250,000.
Balance sheet
balance sheet total €117,116 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
80.8%
Higher than 71% of 20,767 companies in 2025.
4.89
Higher than 68% of 20,341 companies in 2025.
67.7%
Higher than 91% of 20,623 companies in 2025.
Philotax
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
117,116 | 31,863 | |
21/28 |
6,964 | - | |
22/27 |
6,964 | - | |
24 |
6,964 | - | |
29/58 |
110,152 | 31,863 | |
40/41 |
143 | 560 | |
40 |
- | 560 | |
41 |
143 | - | |
54/58 |
55,929 | 2,434 | |
490/1 |
54,080 | 28,869 | |
| Balance sheet: equity and liabilities | |||
10/49 |
117,116 | 31,863 | |
10/15 |
94,600 | 15,289 | |
10/11 |
2,500 | 2,500 | |
14 |
92,100 | 12,789 | |
17/49 |
22,516 | 16,574 | |
42/48 |
22,516 | 14,474 | |
44 |
1,062 | 177 | |
440/4 |
1,062 | 177 | |
45 |
21,454 | 3,499 | |
450/3 |
21,454 | 3,499 | |
47/48 |
- | 10,798 | |
492/3 |
- | 2,100 | |
| Income statement | |||
9900 |
100,875 | 16,305 | |
630 |
834 | - | |
640/8 |
134 | - | |
9901 |
99,907 | 16,305 | |
75/76B |
57 | - | |
75 |
57 | - | |
65/66B |
3 | 18 | |
65 |
3 | 18 | |
9903 |
99,961 | 16,288 | |
67/77 |
20,650 | 3,499 | |
9904 |
79,311 | 12,789 | |
9905 |
79,311 | 12,789 | |
| Appropriation of the result | |||
9906 |
92,100 | 12,789 | |
14P |
12,789 | - | |
| Document | |||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 22-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankSubsidies and aid
Flemish government 2024 to 2025, 2 entries, €480 awarded, €480 paid
| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2025 | 1 | €240 | €240 |
| 2024 | 1 | €240 | €240 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 100,741 | - | ||
| 80,145 | - | ||
| 7,798 | - | ||
| 53,495 | - | ||
| 87,636 | 17,389 | ||
| 80.8% | 48.0% | ||
| 4.89 | 2.20 | ||
| 0.24 | 1.08 | ||
| 83.8% | 83.6% | ||
| 67.7% | 40.1% | ||
| over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Tangible fixed assets | €7,798 | - |
| €834 | - |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on Philotax
The operating result for 2025 is 6.1 times that of 2024.
Debt's share of the balance-sheet total falls from 52.0% to 19.2%. Equity and debt are higher.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
current term since 02-10-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 22-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Het mandaat van bestuurder is als volgt in de tijd beperkt: a. de duur van het mandaat van een (statutair) bestuurder-arts-aandeelhouder is…”deed of 04-10-2024
Mandates through the years
1 name, the dashed line is todayVANHOOREBEECK Cedric
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- VANHOOREBEECK Cedric
- Director (not named in the articles), appointed by deed of 04-10-2024, still in office
Control
Capital
- Contribution
- €2,500
- Shares
- 100
- Contribution per share
- €25
- Equity per share
- €946 in 2025
- Source
- deed of 04-10-2024
Articles of association
deed of 04-10-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Profit allocationThe articles set how profit is distributed. A BV may only pay out after a balance-sheet and liquidity test.
- “Algemene vergadering, op voorstel van het bestuursorgaan, het besluit van de algemene vergadering tot uitkering slechts uitwerking nadat het…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of June at 19:00
Shareholders
At incorporation
deed of 04-10-2024 ↗
- VANHOOREBEECK Cedric 100 shares (100%) · €2,500 in cash
Network & group
No group
Philotax has no parent and no holdings in its annual accounts. VANHOOREBEECK Cedric is the only director. Philotax shares no director with another company.
At the same address
Wittemoerstraat 2, 8730 Beernem · 2 other companies| Dr. Leen Ferlin
registered office since 27-02-2025 · founded in 2025 |
total assets €13,110 (2025) 1020.504.930 |
| Ferlin, Leen (sole trader)
establishment since 16-09-2019 |
founded in 2019 0729.677.055 |
Timeline
Timeline
6 events since 2024Filings
Financial
Establishments
202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 9 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:1014546160
2025
Liquidity more than doubled current ratio 4.89 The current ratio rises from 2.20 to 4.89.
Annual accounts 2024 filed NBBmicro format · 7 days late
2024
IncorporationFounding capital of €2,500, 100 shares · Founder: VANHOOREBEECK Cedric · Appointment: VANHOOREBEECK Cedric (director) · published on 04-10-20245 points ▸
- Founder, VANHOOREBEECK Cedric
- Founding capital, €2,500, 100 shares
- Capital, €2,500, 100 shares
- Registered office clause, Wittemoerstraat 2, 8730 Beernem (Oedelem)
- Director appointment, VANHOOREBEECK Cedric (director (not named in the articles))
- The deed holds 1 more point.
First establishment Wittemoerstraat 2, Beernem
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 2 October 2024, Philotax was incorporated as a private limited company by one natural person, with a starting capital of €2,500.12 VANHOOREBEECK Cedric has served as director since 2024.3 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3
Company details
Identity
- Enterprise number
- 1014.546.160
- VAT number
- BE 1014.546.160
- Peppol ID
- 0208:1014546160
- Other Peppol ID
- 9925:BE1014546160
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 02-10-2024
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of June at 19:00deed of 04-10-2024 (in Dutch)
- Voting ruleThe articles set which majority the meeting decides by, for example a simple or a special majority.
- “Ongeacht het aantal aanwezige of vertegenwoordigde aandelen, meerderheid van stemmen”deed of 04-10-2024 (in Dutch)
- Peppol
- Reachable since 16-01-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- Philotax in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 04-10-2024 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Vlaams Gewest”deed of 04-10-2024 (in Dutch)
Activities
NACEBEL 202586220
Specialist medical practice main activity
85599
Other education
Codes under NACEBEL 2008
86220
Human health activities main activity
85599
Other education
86909
Human health activities
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “De uitoefening van de geneeskunde, meer bepaald de beroepsactiviteit van psychiater - geneesheer specialist door de artsen-aandeelhouders in…”deed of 04-10-2024 (in Dutch)
13 activities
- De uitoefening van de geneeskunde, meer bepaald de beroepsactiviteit van psychiater - geneesheer specialist door de artsen-aandeelhouders in naam en voor rekening van de vennootschap, in binnen- en buitenland, volgens de medische plichtenleer en onder de specifieke beroepsaansprakelijkheid van de vennoten, zoals bepaald door de raad van de Orde van Artsen.
- De arts die een patiënt behandelt, zal bijgevolg tegenover deze laatste, als arts persoonlijk aansprakelijk blijven.
- De arts dient verzekerd te zijn voor medische fouten. De aansprakelijkheid van de vennootschap dient gewaarborgd te zijn.
- Het ter beschikking stellen van alle nodige middelen voor de arts, voor het beheren van een praktijk.
- Het inrichten van de algemene diensten, en een medisch secretariaat in het bijzonder, die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten.
- De aankoop, het huren, het leasen, en het invoeren van alle medische apparatuur die nuttig of nodig zijn voor het gebruik en beheer van de medische apparatuur en begeleidende accommodaties voor voornoemde activiteiten.
- De mogelijkheid scheppen om de arts toe te laten zich verder te bekwamen in zijn discipline, dit teneinde een kwalitatief hoogstaande praktijkvoering mogelijk te maken.
- Het occasioneel verstrekken van onderwijs en het geven van lezingen over voormelde medische onderwerpen, het schrijven en laten publiceren van medische artikels en boeken, het optreden als stagebegeleider.
- De vennootschap mag deelnemen aan alle andere vennootschappen die een gelijkaardig voorwerp nastreven of toetreden tot associaties, met dezelfde of aanvullende specialiteiten, evenwel onder de voorwaarde van voorafgaandelijke goedkeuring door de Provinciale Raad van de Orde der Artsen waaronder de vennootschap ressorteert.
- Overeenkomsten die artsen niet mogen afsluiten met andere artsen of derden, zullen echter door de vennootschap niet mogen afgesloten worden.
- Alle inkomsten voortvloeiend uit de medische activiteit worden geïnd voor en door de vennootschap, zoals alle uit de medische activiteit voortvloeiende uitgaven door de vennootschap vereffend worden.
- De vennootschap kan zonder afbreuk te doen aan de medische plichtenleer ter zake, onder het normaal beheer als voorzichtig en redelijk persoon, een bestemming geven aan haar gereserveerde winsten van welke aard ook. De vennootschap kan bijgevolg, als bijkomstig voorwerp, investeringen en beleggingen, zoals onder andere de aankoop, de verhuring en oprichting van gebouwen, uitvoeren.
- De vennootschap mag in het algemeen alles doen wat rechtstreeks in verband staat met haar voorwerp, dit alles in overeenstemming met de wetten op de deontologie en de medische plichtenleer, eigen aan het beroep van arts.
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Wittemoerstraat 2 registered office 8730 Beernem | 02-10-2024 | 2.365.264.529 |
Buildings and parcels at the address
- Ground area
- 1,469 m²
- Buildings
- 149 m²
- Volume, LiDAR
- 913 m³
- Tallest building
- 9.6 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 31021B1673/00G000 | 1,469 m² | 1 · 149 m² | 9.6 m · 2 |